Purpose: Tumor motion during irradiation reduces target coverage and increases dose to healthy tissues. The standard clinical approaches using margins are overly conservative because they only take into account the maximum amplitude of the movement. Comparable coverage and reduced dose to healthy organs appears achievable with robust motion-adaptive treatment planning, based on the nominal expected probability distribution of target position, and considering the uncertainty of its realization during treatment. We test a robust approach to IMRT [Chan et al. Phys Med Biol 51:2567-2583 (2006] using patient data, to evaluate the effect of target motion variability and the MLC motion interplay on the outcome.
